Other · developed by Supernus Pharmaceuticals
SPN-538 is a drug studied in migraine and headache disorders.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT04050293 | Phase 4 | Migraine Disorders | Terminated | SUPN |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Headache DisordersMigraine Disorders
Updated Nov 1, 2026. Something wrong or missing? Report it on the SUPN page.
See SUPN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
SUPN catalysts and pipeline →